Uti - Healthcare Fund
UTI Mutual Fund Β· FM: Kamal Gada Β· INF789F01TO9 Β· Direct
NAV βΉ392.26 AUM βΉ1371 Cr as of 22 Sep 2026
Portfolio as of Jul 2026 Β· Last Update: 16-Aug-2026 05:01 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.5% | +1.0% | +7.6% | +26.9% | +17.7% | +25.1% | +16.0% | 26/234 | 1.33% |
Equity allocation
96.15%
Non-equity allocation (combined)
3.85%
All Equity Holdings (43) as of Jul 2026
| # | Company | Value (βΉ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | EQ - SUN PHARMACEUTICALS INDUSTRIES | 119.4 | 8.71% | β |
| 2 | EQ - DIVIS LABORATORIES LTD. | 76.3 | 5.57% | β |
| 3 | EQ - AJANTA PHARMA LTD. | 65.8 | 4.80% | β |
| 4 | EQ - CAPLIN POINT LABORATORIES LTD | 54.1 | 3.95% | β |
| 5 | EQ - LUPIN LTD. | 49.2 | 3.59% | β |
| 6 | EQ - GLAND PHARMA LTD. | 48.8 | 3.56% | β |
| 7 | EQ - APOLLO HOSPITALS ENTERPRISE LT | 47.5 | 3.46% | β |
| 8 | EQ - DR REDDYS LABORATORIES LTD. | 42.5 | 3.10% | β |
| 9 | EQ - ALKEM LABORATORIES LTD | 42.5 | 3.10% | β |
| 10 | EQ- GLOBAL HEALTH LTD. | 38.5 | 2.81% | β |
| 11 | EQ - MAX HEALTHCARE INSTITUTE LTD | 37.9 | 2.76% | β |
| 12 | EQ - IPCA LABORATORIES LTD. | 36.7 | 2.68% | β |
| 13 | EQ - FORTIS HEALTHCARE LTD. | 35.4 | 2.58% | β |
| 14 | EQ - ANTHEM BIOSCIENCES LTD | 34.3 | 2.50% | β |
| 15 | EQ - PROCTOR & GAMBLE HEALTH LTD | 33.0 | 2.41% | β |
| 16 | EQ - RAINBOW CHILDRENS MEDICARE LTD | 32.0 | 2.34% | β |
| 17 | EQ - SAI LIFE SCIENCES LTD | 30.2 | 2.20% | β |
| 18 | EQ- JUPITER LIFE LINE HOSPITALS LTD | 29.9 | 2.18% | β |
| 19 | EQ - COHANCE LIFESCIENCES LIMITED | 29.8 | 2.17% | β |
| 20 | EQ - MARKSANS PHARMA LTD. | 29.7 | 2.17% | β |
| 21 | EQ - GLENMARK PHARMACEUTICALS LTD. | 28.9 | 2.11% | β |
| 22 | EQ - VIYASH SCIENTIFIC LTD | 27.2 | 1.98% | β |
| 23 | EQ - ASTER DM QUALITY CARE LIMITED | 26.6 | 1.94% | β |
| 24 | EQ - AUROBINDO PHARMA LTD. | 25.3 | 1.84% | β |
| 25 | EQ - SUDEEP PHARMA LIMITED | 23.4 | 1.71% | β |
| 26 | EQ - DR LAL PATHLABS LTD. | 22.9 | 1.67% | β |
| 27 | EQ - METROPOLIS HEALTHCARE LTD | 22.5 | 1.64% | β |
| 28 | EQ - CIPLA LTD. | 22.1 | 1.61% | β |
| 29 | EQ - BIOCON LTD. | 21.2 | 1.55% | β |
| 30 | EQ - ERIS LIFESCIENCES LTD | 18.3 | 1.33% | β |
| 31 | EQ - VIJAYA DIAGNOSTIC CENTRE LTD | 17.8 | 1.30% | β |
| 32 | EQ - PFIZER LIMITED | 16.6 | 1.21% | β |
| 33 | EQ - WINDLAS BIOTEC LTD | 16.0 | 1.17% | β |
| 34 | EQ - ALEMBIC PHARMACEUTICALS | 15.9 | 1.16% | β |
| 35 | EQ - BLUE JET HEALTHCARE LTD | 15.5 | 1.13% | β |
| 36 | EQ - LAXMI DENTAL LIMITED | 14.0 | 1.02% | β |
| 37 | EQ - EMCURE PHARMACEUTICALS LTD | 13.6 | 0.99% | β |
| 38 | EQ - SANOFI CONSUMER HEALTHCARE INDIA LTD | 11.1 | 0.81% | β |
| 39 | EQ - KRISHNA INSTITUTE OF MEDI SCIE | 11.1 | 0.81% | β |
| 40 | EQ - AARTI PHARMALABS LTD | 10.0 | 0.73% | β |
| 41 | EQ - ORCHID PHARMA LTD. | 10.0 | 0.73% | β |
| 42 | EQ - JUBILANT PHARMOVA LIMITED | 8.4 | 0.61% | β |
| 43 | EQ - SYNGENE INTERNATIONAL LTD. | 6.3 | 0.46% | β |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.